| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $219,283,089 ) (Continued on the next page) |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01DK128166 | LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi | 001 | 3 | NIH | 5/6/2024 | $31,030 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01DK128166 | LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi | 000 | 3 | NIH | 12/22/2023 | $465,480 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01HD099162 | Molecular mechanisms underlying vocal communication | 000 | 5 | NIH | 11/28/2023 | $354,597 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01CA244341 | Characterization and targeting of rapid nucleotide exchange RAS mutations | 001 | 5 | NIH | 4/17/2024 | $18,758 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01CA244341 | Characterization and targeting of rapid nucleotide exchange RAS mutations | 000 | 5 | NIH | 1/23/2024 | $337,635 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01DK130892 | A human genetic variant ties defective hypothalamic development to obesity and diabetes | 001 | 3 | NIH | 5/15/2024 | $24,600 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01DK130892 | A human genetic variant ties defective hypothalamic development to obesity and diabetes | 000 | 3 | NIH | 12/28/2023 | $368,999 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01AI167920 | The Role of Pacs1-Wdr37 inLymphocyte Quiescence and Survival | 001 | 3 | NIH | 5/24/2024 | $41,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01AI167920 | The Role of Pacs1-Wdr37 inLymphocyte Quiescence and Survival | 000 | 3 | NIH | 1/3/2024 | $369,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01DK125713 | The role of ascorbate in myelopoiesis and infection | 001 | 4 | NIH | 5/6/2024 | $21,648 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01DK125713 | The role of ascorbate in myelopoiesis and infection | 000 | 4 | NIH | 1/25/2024 | $324,720 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01HL161387 | The role of glycolysis and glucose oxidation in hematopoiesis | 000 | 3 | NIH | 1/24/2024 | $402,960 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | P01HL160487 | New Approaches to Reduce Residual Cardiovascular Risk | 001 | 3 | NIH | 6/8/2024 | $198,767 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | P01HL160487 | New Approaches to Reduce Residual Cardiovascular Risk | 000 | 3 | NIH | 12/27/2023 | $2,236,141 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01HL157281 | Transcriptional Control of Neonatal Heart Regeneration | 001 | 3 | NIH | 6/24/2024 | $45,204 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01DK130959 | The Role of Gm4951 in Nonalcoholic Fatty Liver Disease | 001 | 3 | NIH | 5/15/2024 | $21,648 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01DK130959 | The Role of Gm4951 in Nonalcoholic Fatty Liver Disease | 000 | 3 | NIH | 12/8/2023 | $324,720 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01HL157281 | Transcriptional Control of Neonatal Heart Regeneration | 000 | 3 | NIH | 11/6/2023 | $508,532 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01CA258602 | Cancer Resistant Mice | 001 | 3 | NIH | 4/17/2024 | $34,030 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01CA258602 | Cancer Resistant Mice | 000 | 3 | NIH | 11/14/2023 | $612,519 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01AI153724 | Development of a vaccination platform for emerging flavivirus infections | 002 | 3 | NIH | 5/13/2024 | $45,976 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01AI153724 | Development of a vaccination platform for emerging flavivirus infections | 001 | 3 | NIH | 10/23/2023 | $413,792 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | F30CA254150 | The Role of Glucose-6-Phosphatase in Hepatocellular Carcinoma | 001 | 4 | NIH | 5/7/2024 | $1,280 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | F30CA254150 | The Role of Glucose-6-Phosphatase in Hepatocellular Carcinoma | 000 | 4 | NIH | 12/8/2023 | $38,550 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01NS125250 | Behavioral and pharmacological manipulation of time cell activity in the human mesial temporal lobe | 001 | 3 | NIH | 5/3/2024 | $25,926 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01NS125250 | Behavioral and pharmacological manipulation of time cell activity in the human mesial temporal lobe | 000 | 3 | NIH | 11/7/2023 | $333,334 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R35GM154877 | Proteostasis and Phosphate Sensing in the Regulation of the Phosphate Transporter SLC20A1 | 000 | 1 | NIH | 7/23/2024 | $410,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R00AI166036 | Mechanistic Dissection and Antibiotic Discovery Targeting Clostridioides difficile RNA Polymerase | 000 | 3 | NIH | 7/22/2024 | $249,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 Harry Hines Blvd | Dallas | TX | 75390-7208 | DALLAS | USA | T0839278 | Scholarships for Disadvantaged Students | 00 | 5 | HRSA | 5/24/2024 | $648,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01NS138271 | Uncovering the Mechanisms of Amylopectinosis in LUBAC Deficiency | 000 | 1 | NIH | 7/22/2024 | $410,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R00CA252009 | Function of mesothelial cells in the tumor microenvironment of pancreatic ductal adenocarcinoma | 001 | 4 | NIH | 4/17/2024 | $24,900 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R00CA252009 | Function of mesothelial cells in the tumor microenvironment of pancreatic ductal adenocarcinoma | 000 | 4 | NIH | 11/10/2023 | $224,100 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | K99AG075161 | WNK1/OSR1 axis in Hippocampal Insulin Signaling, Glucose Metabolism and Age-related Cognitive Dysfunction | 000 | 2 | NIH | 11/1/2023 | $132,300 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R61HL167909 | A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent Exacerbations | 000 | 1 | NIH | 7/18/2024 | $790,698 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01AG076529 | Lipid sensing through G protein geranylgeranylation | 001 | 3 | NIH | 6/10/2024 | $33,591 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01AG076529 | Lipid sensing through G protein geranylgeranylation | 000 | 3 | NIH | 1/25/2024 | $302,309 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R21AG086710 | Unmasking p38 MAPK Functions in Lysosome Homeostasis during Development and Aging | 000 | 1 | NIH | 7/18/2024 | $451,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | S10MH137076 | Advanced Serial Two Photon Tomography System for Neuroscience Research | 000 | 1 | NIH | 7/19/2024 | $600,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | K01DK131252 | Interaction of Mesenteric Adipose Tissue Physiology, Expansion, and Inflammation with Inflammatory Bowel Disease | 000 | 2 | NIH | 1/26/2024 | $134,775 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R21AI168698 | Regulation and Function of Human Polyomavirus circular RNAs | 001 | 2 | NIH | 5/14/2024 | $16,605 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R21AI168698 | Regulation and Function of Human Polyomavirus circular RNAs | 000 | 2 | NIH | 10/25/2023 | $149,446 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01MD017529 | Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population | 001 | 3 | NIH | 5/29/2024 | $50,272 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R21AI180551 | Characterization of a Novel FACT-ETS-1 Antiviral Response Pathway and Identification of RNA Virus-Encoded Antagonists of this Host Response | 000 | 1 | NIH | 12/5/2023 | $221,400 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01MH135952 | The impact of DNA supercoiling and topoisomerases on neuronal activity-dependent chromatin organization | 000 | 1 | NIH | 7/19/2024 | $530,696 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01AI167967 | Drug Target Discovery, Validation, and Prioritization for Schistosomiasis | 001 | 2 | NIH | 5/14/2024 | $81,929 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01MD017529 | Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population | 000 | 3 | NIH | 1/23/2024 | $646,330 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R01AI167967 | Drug Target Discovery, Validation, and Prioritization for Schistosomiasis | 000 | 2 | NIH | 11/15/2023 | $737,359 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | R21CA288895 | Jumonji enzyme action in hepatocellular carcinoma onset | 000 | 1 | NIH | 1/19/2024 | $191,675 |
| 2024 | 2024 | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE | 5323 HARRY HINES BLVD | DALLAS | TX | 75390-7208 | DALLAS | USA | K08HL172012 | Characterization of PHF7 function in mediating cardiac reprogramming | 000 | 1 | NIH | 12/18/2023 | $156,600 |
|